CLN3 is required for the clearance of glycerophosphodiesters from lysosomes
Nouf N. Laqtom(Stanford University), Monther Abu-Remaileh(Neurosciences Institute), Christian Grimm(University of Oxford), Caroline A. Lewis(Whitehead Institute for Biomedical Research), Andrew L. Cangelosi(Allen Institute), Uche N. Medoh(Stanford University), Alessandro Ori(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Wentao Dong(Zhejiang University), Tenzin Kunchok(Whitehead Institute for Biomedical Research), Forbes D. Porter(National Institutes of Health), Sze Ham Chan(Whitehead Institute for Biomedical Research), Ivonne Heinze(Leibniz Institute on Aging - Fritz Lipmann Institute (FLI)), Rachel Tang(Ludwig-Maximilians-Universität München), Vimisha Dharamdasani(Whitehead Institute for Biomedical Research), An Dang(Eunice Kennedy Shriver National Institute of Child Health and Human Development), David M. Sabatini(Czech Academy of Sciences, Institute of Organic Chemistry and Biochemistry)
Cited by 139
Related Papers
Systematic RNA interference reveals that oncogenic KRAS-driven cancers require TBK1
|Nature|2009|4.2k
mTOR signaling at a glance
|Journal of Cell Science|2009|2.1k
Functional genomics reveal that the serine synthesis pathway is essential in breast cancer
|Nature|2011|1.7k